Senti Bio to Participate in Upcoming Investor Conferences

(marketscreener.com) SOUTH SAN FRANCISCO, Calif., April 14, 2023 -- Senti Biosciences, Inc. , a biotechnology company innovating next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced its participation at the following investor conferences: Chardan’s 7th Annual Genetic Medicines and Cell Therapy...https://www.marketscreener.com/quote/stock/SENTI-BIOSCIENCES-INC-139248437/news/Senti-Bio-to-Participate-in-Upcoming-Investor-Conferences-43495978/?utm_medium=RSS&utm_content=20230414